How the pandemic and George Floyd made clinical trial diversity a priority
July 05, 2022
Clario Chief Diversity, Inclusion & Sustainability Officer Otis Johnson, PhD, MPA, sat down with Drug Discovery and Development to discuss how COVID-19 shone a light on the lack of diversity in clinical trials. Read the full article here.